Human L-Dopa decarboxylase interaction with annexin V and expression during apoptosis.


Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 06 06 2020
revised: 30 07 2020
accepted: 17 08 2020
pubmed: 25 8 2020
medline: 28 5 2021
entrez: 25 8 2020
Statut: ppublish

Résumé

l-Dopa Decarboxylase (DDC) is a pyridoxal requiring enzyme that catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (l-Dopa) to Dopamine (DA). The function of DDC in physiological and pathological biochemical pathways remains poorly understood, while the function and regulation of human DDC isoforms is almost completely elusive. We have shown that Annexin V, a fundamental apoptosis marker, is an inhibitor of l-Dopa decarboxylase activity. Here we show the interaction of both the full-length DDC and the truncated isoform alternative DDC (Alt-DDC) with Annexin V in human tissue and cell lines. Interestingly, DDC isoform expression is enhanced or remains unaffected following staurosporine (STS) treatment, despite increased levels of cytotoxicity and apoptosis. The findings presented here provide novel insights concerning the involvement of DDC in programmed cell death.

Identifiants

pubmed: 32835737
pii: S0300-9084(20)30194-2
doi: 10.1016/j.biochi.2020.08.010
pii:
doi:

Substances chimiques

Annexin A5 0
Enzyme Inhibitors 0
Protein Isoforms 0
Cobalt 3G0H8C9362
Aromatic-L-Amino-Acid Decarboxylases EC 4.1.1.28
DDC protein, human EC 4.1.1.28
cobaltous chloride EVS87XF13W
Staurosporine H88EPA0A3N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-86

Informations de copyright

Copyright © 2020 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Ioanna Chalatsa (I)

Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece; Neurodegenerative Diseases Division, Center for Basic Research, Foundation for Biomedical Research of the Academy of Athens, 4 Soranou Ephessiou Street, 115 27, Athens, Greece.

Nikolaos Arvanitis (N)

Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece.

Dimitrios Arvanitis (D)

Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece.

Anastasia C Tsakou (AC)

Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece.

Evangelos D Kalantzis (ED)

Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece.

Alice G Vassiliou (AG)

1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, Evangelismos Hospital, Athens Medical School, National & Kapodistrian University of Athens, Athens, Greece.

Diamantis C Sideris (DC)

Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece.

Efseveia Frakolaki (E)

Laboratory of Molecular Virology, Hellenic Pasteur Institute (HPI), Vas. Sofias 127 av, 11521, Athens, Greece.

Niki Vassilaki (N)

Laboratory of Molecular Virology, Hellenic Pasteur Institute (HPI), Vas. Sofias 127 av, 11521, Athens, Greece.

Dido Vassilacopoulou (D)

Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece. Electronic address: didovass@biol.uoa.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH